# US 2010/0168041 A1 · Combination of monosaccharides and desquamating agents, and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168041 A1
- Document ID: US20100168041A1
- Status: Published application
- Kind: A1
- Application number: 12/649,372
- Filed: 2009-12-30
- Published: 2010-07-01
- Earliest claimed: 2008-12-30
- Assignees: L'oreal
- Inventors: Julien LABOUREAU; Jean-Thierry Simonnet; Pascal Portes
- Web page: https://patentgrep.com/patent/US20100168041A1

## CPC

- A61K 8/062: {Oil-in-water emulsions}
- A61K 8/365: Hydroxycarboxylic acids; Ketocarboxylic acids
- A61K 8/368: with carboxyl groups directly bound to carbon atoms of aromatic rings
- A61K 8/60: Sugars; Derivatives thereof
- A61P 17/14: for baldness or alopecia
- A61P 17/18: Antioxidants, e.g. antiradicals (preparations for protection against sunlight A61Q17/00)
- A61Q 19/00: Preparations for care of the skin
- A61Q 19/08: Anti-ageing preparations
- A61K 2800/28: Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
- A61K 2800/87: Application Devices; Containers; Packaging
- A61K 2800/91: Injection
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention relates to a composition, especially a cosmetic and/or dermatological composition, containing, in a physiologically acceptable medium, a combination of at least one monosaccharide chosen from mannose, rhamnose and a mixture thereof, and of at least one desquamating agent. The present invention also relates to the use of such a composition, and to a device containing it.

## Claims

### Claim 1

A method for at least one of the following:
for improving the radiance of the complexion,
for reducing and/or preventing the characteristics of wrinkles and/or fine lines,
for improving and/or reducing the microrelief of the skin, and/or for making the skin smooth and/or for promoting desquamation of the skin and/or stimulating epidermal renewal,
for improving the density and/or firmness of the skin,
for preventively or curatively treating withered skin, lack of skin elasticity and/or tonicity, thinning of the dermis, degradation of collagen fibres, flaccid skin and/or thinned skin.
comprising applying to human skin in need thereof a composition comprising, in a physiologically acceptable medium, at least one monosaccharide chosen from mannose and rhamnose and at least one desquamating agent.

### Claim 2 (depends on 1)

The method according to claim 1, which is for improving the density and/or firmness of the skin.

### Claim 3 (depends on 1)

The method according to claim 1, which is for preventively or curatively treating withered skin, lack of skin elasticity and/or tonicity, thinning of the dermis, degradation of collagen fibres, flaccid skin and/or thinned skin.

### Claim 4

A composition comprising, in a physiologically acceptable medium, a combination of at least one monosaccharide chosen from mannose and rhamnose and at least one desquamating agent, the desquamating agent being chosen from jasmonic acid, gentisic acid, a jasmonic acid derivative, a gentisic acid derivative, and salicylic acid derivatives.

### Claim 5 (depends on 4)

A composition according to claim 4, comprising a salicylic acid derivative chosen from 5-n-octanoylsalicylic acid (or capryloylsalicylic acid); 5-n-decanoylsalicylic acid; 5-n-dodecanoylsalicylic acid; 5-n-heptyloxysalicylic acid, and salts thereof.

### Claim 6 (depends on 4)

A composition according to claim 4, comprising at least one compound chosen from:
3-hydroxy-2-[(2Z)-pentenyl]cyclopentaneacetic acid,
methyl 3-hydroxy-2-[(2Z)-pentenyl]cyclopentaneacetate,
2-[(2Z)-2-pentenyl]-3-hydroxycyclopentaneethanol,
3-hydroxy-2-pentylcyclopentaneacetic acid,
methyl 3-hydroxy-2-pentylcyclopentaneacetate,
2-pentyl-3-hydroxycyclopentaneethanol, and
jasmonic acid.

### Claim 7 (depends on 4)

A composition according to claim 4, comprising 0.001% and 30% by weight relative to the total weight of the composition of said at least one monosaccharide

### Claim 8 (depends on 4)

A composition according to claim 4, in which the amount of desquamating agent is 0.001%-30% by weight relative to the total weight of the composition.

### Claim 9

A device comprising a combination of at least one monosaccharide chosen from mannose and rhamnose and at least one desquamating agent, the device being capable of delivering said combination by intraepidermal and/or intradermal and/or subcutaneous injection.
